Global Nitrosamines Testing Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Nitrosamines Testing Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Nitrosamine Testing is a method to detect the presence and quantity of nitrosamines in foods or medicines.

Nitrosamines are a class of carcinogen impurities, which are formed by the reaction of secondary amines, amides, carbamates, derivatives of urea and nitrite or other nitrogenous compounds with nitrogen in the +3 state. Nitrosamines became a greater focus for the pharmaceutical industry following a series of recalls related to contamination. Nitrosamines can be found in low concentrations in a variety of sources, including API’s and Excipients.

Market Overview:

The latest research study on the global Nitrosamines Testing market finds that the global Nitrosamines Testing market reached a value of USD 119.32 million in 2022. It’s expected that the market will achieve USD 209.64 million by 2028, exhibiting a CAGR of 9.85% during the forecast period.

Influence of COVID-19 Outbreak on Nitrosamines Testing Industry Development

COVID-19 has a great impact on small and medium-sized private enterprises represented by catering, tourism, manufacturing and so on, and some Nitrosamines Testing are also facing severe challenges to varying degrees.
Due to the influence of COVID-19, the delayed resumption of work due to the request of the local government will directly affect the failure of the project to be completed and delivered on time. Measures such as stopping production or restricting the flow of personnel and materials are also taken in the place where the labor and consumables required by Nitrosamines Testing are located, which indirectly affects the progress. At the same time, due to the influence of COVID-19, labor and consumables are in short supply and related expenses are rising, resulting in a substantial increase in costs.
In the short term, the most fundamental negative impact of COVID19 on Nitrosamines Testing Industry is the funding problem, especially the cash flow difficulties of small, medium and micro testing enterprises continue to enlarge. capital is the lifeline of enterprises, and solving the short-term capital problem is the first priority for enterprises to survive. Enterprises can solve the problem of short-term capital turnover through accounts receivable factoring, capital borrowing, tripartite contract mortgage pawn, mutual insurance, joint insurance and other forms.
In the long-term, COVID-19 has promoted the development of Nitrosamines Testing Industry. Under the impact of COVID-19, many small and medium-sized enterprises have closed down, which is equivalent to an industry reshuffle, the survival of the fittest, and helping the industry to adjust the market.
On the other hand, COVID-19 has increased the R&D and production of related drugs. Nitrosamines Testing is essential in the process of drugs from R&D to market.

Limitations

In recent years, various pharmaceutical products (DPs) have been recalled from the market due to the detection of nitrosamine impurities. In order to identify the source of nitrosamine impurities in pharmaceutical products, various drug regulatory agencies and the entire pharmaceutical industry have conducted extensive investigations. The US FDA listed at least seven possible root causes for the introduction of nitrosamine impurities in the latest version of the guidance (2020), and the latest EMA guidance also published 11 possible sources. The diversity and uncertainty of such sources make it extremely difficult to accurately detect nitrosamine impurities in pharmaceuticals.
If both secondary amines and nitrites are present under acidic conditions, the two may react to form nitrosamine impurities. In addition to the material itself with a secondary amine structure, tertiary amines and quaternary ammonium reagents may also introduce secondary amine impurities; Amide reagents are also considered another source of secondary amines. In addition, contamination of raw materials purchased from suppliers may also introduce nitrosamine-like impurities. If recycled materials such as solvents, reagents and catalysts are used in the production process, there also may be a risk of introducing nitrosamine-like impurities due to impurities such as residual amines.

Region Overview:

From 2023-2028, North America is estimated to witness robust growth prospects.

Company Overview:

Eurofins is one of the major players operating in the Nitrosamines Testing market, holding a share of 19.91% in 2022.

Eurofins providing testing and support services to the pharmaceutical, food, environmental, agriscience and consumer products industries and to governments.

SGS is engages in the provision of inspection, verification, testing, certification and quality assurance services. It operates through the following segments: Agriculture, Food and Life; Mineral Services; Oil, Gas and Chemicals Services; Consumer and Retail Services; Certification and Business Enhancement; Industrial Services; Environment, Health and Safety Services; Transportation Services; and Governments and Institutions Services. The company was founded in 1878 and is headquartered in Geneva, Switzerland.

Segmentation Overview:

Among different product types, Gas Chromatography and Mass Spectrometry segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Pharmaceutical Industry segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Nitrosamines Testing market covered in Chapter 3:

KYMOS Group
EKG Life Science Solutions, LLC (EKG Labs)
Canadian Analytical Laboratories
Nucro-Technics
Selvita
SGS
AMPAC Analytical
Eurofins
Alcami Corporation, Inc.
Boston Analytical

In Chapter 4 and Chapter 14.2, on the basis of types, the Nitrosamines Testing market from 2018 to 2029 is primarily split into:

Liquid Chromatography and Mass Spectrometry
Gas Chromatography and Mass Spectrometry

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Nitrosamines Testing market from 2018 to 2029 covers:

Pharmaceutical Industry
Chemical Industry
Food Industry
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)